Facultad de Medicina

Search results

• To maintain or not the use of masks in schools? Debate grows over restrictions on school grounds

  Cinthya Urquidi Bellota

  18/08/22

  1 item of Media coverage

  Press/Media

• Do we really need a fifth dose? Expert debate on a new booster against Covid-19

  Cinthya Urquidi Bellota

  8/08/22

  1 item of Media coverage

  Press/Media

• What are the warning signs of head and neck cancer?

  Marcela Cárcamo

  27/07/22

  1 item of Media coverage

  Press/Media

• Patient Dosed With Mesenchymal Stem Cell-Derived Therapy for Osteoarthritis

  Maroun Khoury

  25/07/22

  1 item of Media coverage

  Press/Media

• CELLS for CELLS Treats the First-Ever Patient with an Exosome-Produced Therapy for Osteoarthritis

  Maroun Khoury

  19/07/22

  1 item of Media coverage

  Press/Media

• CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis

  Maroun Khoury

  18/07/22 → 19/07/22

  20 items of Media coverage

  Press/Media

• Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis

  Maroun Khoury

  19/07/22

  1 item of Media coverage

  Press/Media

• More than 48,000 people have required emergency mental health care this year.

  Miguel Prieto

  19/03/22

  1 item of Media coverage

  Press/Media

• Cell for Cells starts cell therapy operations in the U.S. and closes agreement with the University of Miami

  Maroun Khoury

  18/02/22

  1 item of Media coverage

  Press/Media

• Demand for home PCR increases due to rise in number of infected patients

  David Torres

  3/02/22

  1 item of Media coverage

  Press/Media

• Revolutionary Chilean center will research the generation of new tissues and the use of cells to treat patients

  Maroun Khoury

  2/01/22

  1 item of Media coverage

  Press/Media

• GEL-X: vida útil a los desperdicios del salmón

  Javier Enrione

  24/10/21

  1 item of Media coverage

  Press/Media

• Clinical Trial: Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1)

  Francisco Espinoza

  29/09/21

  2 items of Media coverage

  Press/Media

• Gel-X: desde suplemento alimentario hasta biotinta para impresión de órganos

  Javier Enrione

  23/09/21

  1 Media contribution

  Press/Media

• Column of Marcela Garrido and Cinthya Urquidi: 18 for sure

  Cinthya Urquidi Bellota

  28/08/21

  1 item of Media coverage

  Press/Media

• Integrated Health Network: 17 facilities in the country do not have Covid patients in their ICUs

  Cinthya Urquidi Bellota

  23/08/21

  1 item of Media coverage

  Press/Media

• Vaccination progress reaches 80.1% in the Metropolitan Region: will cases continue to fall?

  Cinthya Urquidi Bellota

  8/07/21

  1 item of Media coverage

  Press/Media

• US Patent Issued to Cells for Cells on June 22 for "Anti-angiogenic therapy based on exosomes derived from menstrual stem cells" (Chilean Inventors)

  Maroun Khoury

  23/06/21

  1 item of Media coverage

  Press/Media

• US Patent Issued to UNIVERSIDAD DE LOS ANDES on June 15 for "In vitro method for identifying a pregnancy related disease" (Chilean Inventors)

  Alejandra Chaparro

  16/06/21

  1 item of Media coverage

  Press/Media

• US Patent Issued to UNIVERSIDAD DE LOS ANDES on May 18 for "In vitro method for identifying a pregnancy related disease" (Chilean Inventors)

  Alejandra Chaparro

  19/05/21

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'In vitro method for identifying a pregnancy related disease' Lapses

  Alejandra Chaparro

  9/04/21

  1 item of Media coverage

  Press/Media

• VEINTIS™ the tissue-engineered vascular graft developed by Cells for Cells, wins the 2020 National Innovation Prize

  Maroun Khoury & Juan Pablo Acevedo

  13/11/20

  1 item of Media coverage

  Press/Media

• VEINTIS™ the tissue-engineered vascular graft developed by Cells for Cells, wins the 2020 National Innovation Prize

  Juan Pablo Acevedo

  12/11/20 → 13/11/20

  2 items of Media coverage

  Press/Media

• Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells.

  Patricia Alejandra Luz Crawford & Maroun Khoury

  17/10/20

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'Anti-angiogenic therapy based on exosomes derived from menstrual stem cells' Lapses

  Maroun Khoury

  16/10/20

  1 item of Media coverage

  Press/Media